¦~«á2­Ó¤ë´_°·¬ìÃzº¡¡I ®a¬F°ü¤­¤QªÓ¼W¥ÍÀøªk¤£¥dÃö

2021-03-12 1467

ªL¹ÅÃýÂå®vªí¥Ü¡A¿©±w¤­¤QªÓªº±wªÌ±`¦]ªÓ»H¯kµh»øµw¡A¥H­PµLªk§¹¦¨¤é±`¥Í¬¡¤¤Á|¤â¡B®ÞÀY©Î«á¦©¤º¦çªº°Ê§@¡A©]±ß·|¦]¬°¯kµh¥[¼@¬Æ¦Ü¼vÅTºÎ¯v¡C

®Ú¾ÚÁ{§ÉÆ[¹îµo²{¡A¦~«á2­Ó¤ë©¹©¹¥X²{´_°·¬ì´N¶E°ª®p´Á¡A­ì¨Ó¤£¤Ö±C±C¶ý¶ý¦~«e¶Ô³Ò¤j±½°£¡B°µ®a¨Æ¤£·V¶Ë¤ÎªÓ»H¾É­P¯kµh¡A¥H¬°·|³vº¥¦nÂà¡Aµ²ªGº¥º¥µo²{±ß¤WºÎı®É¤]µh¡BªÓ»HÅܱo¬¡°Ê§xÃø¡BÃø¥HÁ|°ªµ¥±¡ªp¡Aª½¨ì¦~«á¤@¬q®É¶¡¤~¨Ó´NÂå¡A¤~µo²{¤­¤QªÓ¤w¤W¨­¡C

¤­¤QªÓ¼vÅT¥Í¬¡«~½è»PºÎ¯v ¤À¬°­ìµo©Ê©M³sÄò©Ê

¤­¤QªÓªº¾Ç¦W¬O¡uªgÂH©ÊªÓÃö¸`Ånª¢¡v¡A¦]Ãö¸`Ånµoª¢ÅÜ«p¡BÅÖºû¤Æ¡A¶i¦Ó¾É­PÃö¸`ªgÂH¡A¼vÅTªÓÃö¸`¬¡°Êµ{«×¡A§Î¦PªÓ»H­áµ²¡A«U¦W¬°¡u¦B­áªÓ¡v¡C±d¥Ý´_°·¬ì¶E©ÒªL¹ÅÃýÂå®vªí¥Ü¡A¿©±w¤­¤QªÓªº±wªÌ±`¦]ªÓ»H¯kµh»øµw¡A¥H­PµLªk§¹¦¨¤é±`¥Í¬¡¤¤Á|¤â¡B®ÞÀY©Î«á¦©¤º¦çªº°Ê§@¡A©]±ß·|¦]¬°¯kµh¥[¼@¬Æ¦Ü¼vÅTºÎ¯v¡C

³q±`¤­¤QªÓ¥i¤À¬°­ìµo©Ê©MÄòµo©Ê¡A«eªÌ¦h¤¶©ó40¦Ü60·³¯f±w¡A¤k©Ê¦h©ó¨k©Ê¡Aµo§@­ì¦]¤£©ú¡A¬ã¨s«ü¥X¥i¯à»P¿}§¿¯f©Î¥Òª¬¸¢¥\¯à¥¢½Õµ¥¯e¯f¦³Ãö¡F«áªÌ¦h¼Æ¦]¬°ªÓ»H¦³¥~¶Ë¡B°©§é¡B¦Ù¦×©Î¦Ù¸x©Ô¶Ë¡A©Î¬O¿©±w­··Ã©ÊÃö¸`ª¢¡A¦]¯kµhªø¤[¤£´±¬¡°Ê©Ò­P¡A¨Ã«D¥u¦³50·³¥ª¥kªº¯f±w¤~·|¿©±w¡C

±d¥Ý´_°·¬ì¶E©ÒªL¹ÅÃýÂå®v»¡©ú¡A°w¹ï¤­¤QªÓ¡AªvÀø¤W·|µ¹¤©ÃĪ«¨Ã¦w±Æ°·«O»ö¾¹´_°·¡A¨C¤Ñ¦b®a¹B°ÊªvÀø©Î¦w±Æª«²zªvÀø®v1¹ï1®{¤âªvÀø¡A©Î¬OÂǥѶW­µªi¾É¤Þª`®gÃĪ«¶i¦æªÓÃö¸`ÅnÂX±i³N¡Aªì´Á±wªÌ¦h¼Æ¿n·¥ªvÀø¬ù1¦Ü3­Ó¤ë¡A´N·|¦³©úÅã§ïµ½¡A­Y¯fµ{¸û¤[¡A´_­ì¦Ü¤Ö»Ý6­Ó¤ë¡C

PLT¼W¥ÍÀøªk­°§CªvÀø¯kµh ­×´_´Á¬Û¹ï¸û§Ö

¦Ü©ó¦p¦ó§PÂ_¤­¤QªÓªgÂHµ{«×¡HªL¹ÅÃýÂå®v¸ÑÄÀ¡A¤@¯ë·|³z¹L²z¾ÇÀˬd¡BÀË´úªÓ»H©}¦±»P¦ù®i¡B¥~±Û»P¤º±Û¡B¥~®i©M¤º¦¬6¤j°Ê§@¡A¨Ã³z¹L¶W­µªiÆ[¹î¶´±a©Î¦Ù¸x¦³µL¨ü·l¡C­Y½T©w¦³²Õ´¯}µõ¨ü¶Ë®É¡A¥i§Q¥Î¶Ç²Îªº°ª¿@«×¸²µå¿}¼W¥ÍªvÀø¡B¦ÛÅé°ª¿@«×¦å¤pªO¦å¼ß¡]Platelet-Rich Plasma, PRP¡^©Îªñ¨Óµo®iªº°ª¯Â«×¦å¤pªO­á´¹¡]Platelet-Lyophilized Treatment, PLT¡^µ¥¼W¥ÍÀøªk¡A«á¨âªÌ­ì²z¬°¥H¦ÛÅé¦å¤pªO¤Àªcªº¥Íªø¦]¤lª`®g¦Ü²Õ´¶Ë³B¡A¥Íªø¦]¤l¨ë¿E²Õ´­«·s­×´_¡A´£¤É³n²Õ´±j«×¥[³t­×´_¡B¶i¦Ó«ì´_ªÓÃö¸`ªº¬¡°Ê«×¡C

ªL¹ÅÃýÂå®v«ü¥X¡A±Ä¥ÎPRP¨C¦¸ª`®g«e¥²¶·©â¦å¡B«ÝÂ÷¤ß«á·í¤Ñ¬I¥´¡A¥Bª`®g®ÉµLªk²K¥[§½³¡³Â¾KÃĦ]¦¹¯kµh·P¸û¬°©úÅã¡F¬Û¸û©óPRP, PLT¥u»Ý³æ¦¸©â¦å250cc§Y¥iµÑ¨ú»s¦¨¦Ü¤Ö10²~SSLab PLT­á´¹¡A¨C²~¤º§t10»õÁû¦å¤pªO¡A3¦~¤º¤´¯à«O¦³¬¡©Ê¡A¨Ï¥Î«e¥i±N­á´¹¦^·»¨Ã²V©M§½³¡³Â¾KÃĨϥΡAª`®g®É¸ûµÎ¾A¡Aµoª¢­×´_´Á¤]¯à¤j´TÁYµu¡C¦]¦¹PLT¼W¥ÍÀøªk¡A¦bÁ{§É¤W¸û¾A¦X©Èµh¡B©È©â¦å©M¸g±`¨ü¶Ë»Ý¶i¦æ¦h¦¸ª`®gªº±wªÌ¡]¨Ò¦p: ±M·~¹B°Ê­û¡^µ¥¡C

¤­¤QªÓ«e´Á³Ì¯kµh ¬¡°ÊÃö¸`¦³§U©Ô¶}ªgÂH³¡¦ì

³q±`¤­¤QªÓªº¯fµ{·|¸g¹Lµoª¢´Á¡B¦B­á´Á¤Î¸Ñ­á´Á¦@3¶¥¬q¡Aµoª¢´Á¯kµh³Ì©úÅã¡A±µµÛ¶i¤J¯kµh¦X¨Ö»øµwªº¦B­á´Á¡A³Ì«á¶i¤J¸Ñ­á´Á¡A¯kµh´î½w¥BªÓÃö¸`¬¡°Ê¨¤«×³vº¥«ì´_¡C¤­¤QªÓªvÀø´Á¶¡¥i¦b®a¤¤½m²ß§ïµ½Ãö¸`¬¡°Ê«×ªºª¦Àð¹B°Ê¡BÀ°§U©Ô¶}ªÓ»H¤º±Û¨¤«×ªº¤ò¤y¾Þ¡A¥H¤ÎÄÁÂ\¹B°Ê°V½m¤âÁu¦h¤è¦V¦ù®i¡A¬Ò¦³§U©Ô¶}Ãö¸`ªgÂH³¡¦ì¡C

ªL¹ÅÃýÂå®v´£¿ô¡A­Yµo²{¦]¯kµh¤£´±¬¡°ÊªÓ»H¡A¦p¦ù¤â®³¤ôªM·P¨ì¯kµh¡Aµoª¢ªì´Á´NÀ³¸Ó¶}©l¿n·¥¤¶¤JªvÀø¡AÁקK¨B¤J¦B­á´Áªº¤­¤QªÓ¡A¤£¶È¼vÅT¥Í¬¡«~½è¡BªvÀø´Á¤]©Ôªø¡C¡]ªL­§±Ó¡þ¥x¥_³ø¾É¡^

¡]¹Ï¡þªL¹ÅÃýÂå®v´£¨Ñ¡^
¨Ó·½¡G¦~«á2­Ó¤ë´_°·¬ìÃzº¡¡I ®a¬F°ü¤­¤QªÓ¼W¥ÍÀøªk¤£¥dÃö
¥X³B¡GNOW°·±d

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');